Clinical Trial Update: A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

View source ↗

Summary

A real-world study is evaluating chidamide in combination with PD-1/PD-L1 inhibitors and anti-angiogenic agents for advanced MSS colorectal cancer. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chidamide (chidamide)
• PD-1/PD-L1 inhibitors (PD-1/PD-L1 inhibitors)

Snippet

Sponsor: Feng Wang | Conditions: Colorectal Cancer Metastatic | Status: NOT_YET_RECRUITING